|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1996-3-25
|
|
pubmed:abstractText |
To study the efficacy and safety of Super Malic, a proprietary tablet containing malic acid (200 mg) and magnesium (50 mg), in treatment of primary fibromyalgia syndrome (FM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
953-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8587088-Cross-Over Studies,
pubmed-meshheading:8587088-Double-Blind Method,
pubmed-meshheading:8587088-Drug Administration Schedule,
pubmed-meshheading:8587088-Drug Combinations,
pubmed-meshheading:8587088-Female,
pubmed-meshheading:8587088-Fibromyalgia,
pubmed-meshheading:8587088-Humans,
pubmed-meshheading:8587088-Magnesium Hydroxide,
pubmed-meshheading:8587088-Malates,
pubmed-meshheading:8587088-Male,
pubmed-meshheading:8587088-Middle Aged,
pubmed-meshheading:8587088-Pilot Projects,
pubmed-meshheading:8587088-Placebos
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study.
|
|
pubmed:affiliation |
Department of Medicine, University of Texas Health Science Center, San Antonio 78284-7874, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
